Beam Therapeutics, Inc. (BEAM)
31.22
-0.83
(-2.59%)
USD |
NASDAQ |
Jan 16, 16:00
31.31
+0.09
(+0.29%)
After-Hours: 20:00
Beam Therapeutics EPS Diluted (Quarterly): -1.099 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Intellia Therapeutics, Inc. | -0.9196 |
| Twist Bioscience Corp. | -0.4491 |
| ANI Pharmaceuticals, Inc. | 1.133 |
| Pacific Biosciences of California, Inc. | -0.1263 |
| Regeneron Pharmaceuticals, Inc. | 13.62 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -112.73M |
| Revenue (Quarterly) | 9.698M |
| Total Expenses (Quarterly) | 122.43M |
| Enterprise Value | 2.244B |
| Gross Profit Margin (Quarterly) | 42.67% |
| Profit Margin (Quarterly) | -1.16K% |
| Earnings Yield | -14.21% |
| Normalized Earnings Yield | -14.37 |